HSR21-060: Real-World Treatment Patterns After Trastuzumab-Based Regimen in Patients With HER2-Positive Metastatic Gastric Cancer in the United States

View More View Less
  • 1 Daiichi Sankyo, Inc., Basking Ridge, NJ
  • | 2 Analysis Group, Inc., Boston, MA
  • | 3 AstraZeneca PLC, Gaithersburg, MD
Restricted access

Corresponding Author: Catherine Fernan, BS
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 73 73 6
PDF Downloads 134 134 6
EPUB Downloads 0 0 0